🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06540300
Enrolling by invitation Not applicable

Effects of Repetitive Transcrannial Magnetic Stimulation on Non-Suicidal Self-Injury

NCT06540300 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing Medical University
Phase
Not applicable
Started
2024-06-30
Last updated
2026-07-24

Condition(s) studied

NSSI

Investigational drug(s) / intervention(s)

rTMS stimulation of left M1

rTMS stimulation of left M1: This study employed low-frequency repetitive transcranial magnetic stimulation (low-frequency rTMS) targeting the left primary motor cortex (M1 area). The stimulation intensity was set at 110% of the resting motor threshold (RMT). The single-session stimulation protocol was as follows: continuous stimulation at 1 Hz for 60 seconds, followed by a 5-second interval, with this cycle repeated 20 times. Thus, the total number of pulses per session was 1,200. Two sessions were administered daily, with a 40-minute interval between sessions. Treatment was conducted for 5 consecutive days per week, with 2 rest days, for a total of 2 weeks (10 treatment days). Each patient received a total of 24,000 pulses throughout the entire course. Sham stimulation utilized identical stimulation parameters as active stimulation (including frequency, intensity, duration, and number of repetitions), but employed a sham coil. This coil was identical in appearance to the active stimulation coil, producing simila

Study summary

Non-suicidal self-injury (NSSI) refers to a series of direct and consequently repeated injuries to one's body without suicidal intent. At present, it has become an important issue of mental disorders. This article focuses on the formation mechanism of NSSI and the intervention effect of rTMS on NSSI patients. At the same time, NSSI patients are collected, a treatment plan is designed to complete a two-week treatment, and the results are analyzed. The aim is to provide theoretical basis for the clinical diagnosis and treatment of NSSI, and also to provide reference for the clinical diagnosis and treatment of NSSI patients.

Eligibility

Sex
ALL
Min age
10 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: 1. Meets the NSSI diagnostic criteria recommended in DSM-5; 2. The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screen for diagnostic compliance; 3. Age :10-55 years old; 4. Right hand; 5. The paitent voluntarily participate and sign the informed consent form for this study (signed by participants under the age of 18 and their families); 6. Able to understand written language and cooperate with questionnaire surveys. Exclusion Criteria: 1. History of severe substance abuse; 2. The patient has other serious mental disorders, neurological disorders, or physical illnesses; 3、Previously experienced epileptic seizures; 4、Pregnant or lactating women; 5、Contraindications to magnetic resonance imaging and transcranial magnetic stimulation; 6、Unable or refused to provide written informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanjing Brain Hospital Nanjing Jiangsu

More Nanjing Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06540300 on ClinicalTrials.gov ↗ ← All trials in China